140 related articles for article (PubMed ID: 34738504)
1. Insights into the structural requirements of triazole derivatives as promising DPP IV inhibitors: computational investigations.
Shah BM; Sagar SR; Trivedi P
J Biomol Struct Dyn; 2022; 40(24):13778-13798. PubMed ID: 34738504
[TBL] [Abstract][Full Text] [Related]
2. Molecular docking and 3D-QSAR studies on beta-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors.
Jiang YK
J Mol Model; 2010 Jul; 16(7):1239-49. PubMed ID: 20069322
[TBL] [Abstract][Full Text] [Related]
3. Combined HQSAR, topomer CoMFA, homology modeling and docking studies on triazole derivatives as SGLT2 inhibitors.
Yu S; Yuan J; Zhang Y; Gao S; Gan Y; Han M; Chen Y; Zhou Q; Shi J
Future Med Chem; 2017 Jun; 9(9):847-858. PubMed ID: 28635308
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
Musoev A; Numonov S; You Z; Gao H
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR studies on triazolopiperazine amide inhibitors of dipeptidyl peptidase-IV as anti-diabetic agents.
Saqib U; Siddiqi MI
SAR QSAR Environ Res; 2009 Jul; 20(5-6):519-35. PubMed ID: 19916112
[TBL] [Abstract][Full Text] [Related]
6. CoMFA and CoMSIA of diverse pyrrolidine analogues as dipeptidyl peptidase IV inhibitors: active site requirements.
Murugesan V; Sethi N; Prabhakar YS; Katti SB
Mol Divers; 2011 May; 15(2):457-66. PubMed ID: 20737212
[TBL] [Abstract][Full Text] [Related]
7. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
Gajjar KA; Gajjar AK
Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
[TBL] [Abstract][Full Text] [Related]
8. 3D QSAR and docking study of gliptin derivatives as DPP-IV inhibitors.
Agrawal R; Jain P; Dikshit SN; Bahare RS
Comb Chem High Throughput Screen; 2013 May; 16(4):249-73. PubMed ID: 23305140
[TBL] [Abstract][Full Text] [Related]
9. A Comparative Study of 1D Descriptors Supported CoMFA and CoMSIA QSAR Models to Gain Novel Insights into 1,2,4-Triazoles Acting As Antitubercular Agents.
Ray R; Shenoy GG; Kumar TNVG
Curr Comput Aided Drug Des; 2021; 17(2):281-293. PubMed ID: 32116196
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Patel BD; Bhadada SV; Ghate MD
Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
[TBL] [Abstract][Full Text] [Related]
11. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
Sainy J; Sharma R
SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
[TBL] [Abstract][Full Text] [Related]
12. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
[TBL] [Abstract][Full Text] [Related]
13.
Shirvani P; Fassihi A
J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
[TBL] [Abstract][Full Text] [Related]
14. Discovery of triazole-based uracil derivatives bearing amide moieties as novel dipeptidyl peptidase-IV inhibitors.
Deng X; Han L; Zhou J; Zhang H; Li Q
Bioorg Chem; 2017 Dec; 75():357-367. PubMed ID: 29096096
[TBL] [Abstract][Full Text] [Related]
15. Effects of Different Dietary Flavonoids on Dipeptidyl Peptidase-IV Activity and Expression: Insights into Structure-Activity Relationship.
Gao F; Fu Y; Yi J; Gao A; Jia Y; Cai S
J Agric Food Chem; 2020 Oct; 68(43):12141-12151. PubMed ID: 33063510
[TBL] [Abstract][Full Text] [Related]
16. Structural insights of dipeptidyl peptidase-IV inhibitors through molecular dynamics-guided receptor-dependent 4D-QSAR studies.
Patil RB; Barbosa EG; Sangshetti JN; Zambre VP; Sawant SD
Mol Divers; 2018 Aug; 22(3):575-583. PubMed ID: 29536226
[TBL] [Abstract][Full Text] [Related]
17. Rational design and synthesis of new tetralin-sulfonamide derivatives as potent anti-diabetics and DPP-4 inhibitors: 2D & 3D QSAR, in vivo radiolabeling and bio distribution studies.
Abd El-Karim SS; Anwar MM; Syam YM; Nael MA; Ali HF; Motaleb MA
Bioorg Chem; 2018 Dec; 81():481-493. PubMed ID: 30243239
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of glycolamide, glycinamide, and β-amino carbonyl 1,2,4-triazole derivatives as DPP-4 inhibitors.
Fuh MT; Tseng CC; Li SM; Tsai SE; Chuang TJ; Lu CH; Yang YC; Tsai HJ; Wong FF
Bioorg Chem; 2021 Sep; 114():105049. PubMed ID: 34147879
[TBL] [Abstract][Full Text] [Related]
19. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors.
Dowlati Beirami A; Hajimahdi Z; Zarghi A
J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening of dipeptidyl peptidase-4 inhibitors using quantitative structure-activity relationship-based artificial intelligence and molecular docking of hit compounds.
Hermansyah O; Bustamam A; Yanuar A
Comput Biol Chem; 2021 Dec; 95():107597. PubMed ID: 34800858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
